Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pia Sormani

Showing results (31-40 of 390) with videos related to

Pageof 39
Sort By:
Neurology|February 8, 2020
Machine learning outperforms human experts in MRI pattern analysis of muscular dystrophiesJasper M Morrow, Maria Pia Sormani
Current Opinion in Neurology|April 6, 2019
Multiple sclerosis: clinical trial design 2019Matteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 18, 2022
Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trialsMirko Capanna, Alessio Signori, Maria Pia Sormani
Neurology|October 27, 2020
Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?Tomas Kalincik, Maria Pia Sormani, Carmen Tur
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical trial design for progressive MS trialsMatteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis and Related Disorders|August 2, 2025
Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysisAngela Albanese, Irene Schiavetti, Maria Pia Sormani
Lifetime Data Analysis|November 16, 2011
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosisPaola Siri, Eric Henninger, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
The quality of reports of randomized trials in multiple sclerosis: a reviewAlessio Signori, Alice Baccino, Maria Pia Sormani
Neurology|December 3, 2020
Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?Maria Pia Sormani, Carmen Tur, Frederik Barkhof
International Journal of MS Care|July 25, 2022
Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future DirectionsBianca Weinstock-Guttman, Maria Pia Sormani, Pavle Repovic
Pageof 39

Showing results (31-40 of 390) with videos related to

Sort By:
Pageof 39
Neurology|February 8, 2020
Machine learning outperforms human experts in MRI pattern analysis of muscular dystrophiesJasper M Morrow, Maria Pia Sormani
Current Opinion in Neurology|April 6, 2019
Multiple sclerosis: clinical trial design 2019Matteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 18, 2022
Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trialsMirko Capanna, Alessio Signori, Maria Pia Sormani
Neurology|October 27, 2020
Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?Tomas Kalincik, Maria Pia Sormani, Carmen Tur
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical trial design for progressive MS trialsMatteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis and Related Disorders|August 2, 2025
Real-world experience with cladribine in the two years since treatment start: A systematic review and meta-analysisAngela Albanese, Irene Schiavetti, Maria Pia Sormani
Lifetime Data Analysis|November 16, 2011
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosisPaola Siri, Eric Henninger, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 13, 2012
The quality of reports of randomized trials in multiple sclerosis: a reviewAlessio Signori, Alice Baccino, Maria Pia Sormani
Neurology|December 3, 2020
Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?Maria Pia Sormani, Carmen Tur, Frederik Barkhof
International Journal of MS Care|July 25, 2022
Predicting Long-term Disability in Multiple Sclerosis: A Narrative Review of Current Evidence and Future DirectionsBianca Weinstock-Guttman, Maria Pia Sormani, Pavle Repovic
Pageof 39